NEW DELHI, Jan 3 (Reuters) - India's drugs regulator said on
Sunday it had given final emergency-use approval for two
coronavirus vaccines, one developed by AstraZeneca and
Oxford University and the other by local company Bharat Biotech.
(Reporting by Aftab Ahmed and Nigam Prusty: Editing by Neil
Fullick)
CORRECT: Angle shares up on assay development deal with AstraZeneca
(Correcting company name in headline)
Read more